Healthcare cold chain logistics market seen reaching $155.6 billion by 2035

Market Research Future projects the global healthcare cold chain logistics market will more than double by 2035, driven by biologics, cell and gene therapies, tighter regulation and vaccine stockpiling. The report points to growing demand for temperature-controlled transport, storage and monitoring across pharma supply chains.

Why it matters: - Healthcare cold chain logistics is becoming a core part of how biologics, vaccines and cell therapies reach patients without losing temperature integrity. - The market’s growth reflects more complex drugs, tighter compliance rules and continued public-health spending on immunization and preparedness. - Market Research Future projects the market will rise from USD 67.5 billion in 2025 to USD 155.6 billion by 2035, at an 8.7% CAGR.

What happened: - Market Research Future released a forecast for the global healthcare cold chain logistics market covering 2026-2035. - The report says the market will reach USD 73.4 billion in 2026, the first year of the forecast window. - The forecast highlights rising biologics and cell therapy pipelines, regulatory tightening and vaccine stockpiling as the main growth engines. - The report includes a free sample request and a detailed report link: Request a free sample and Read the detailed report.

The details: - More than 70 commercial-stage cell and gene therapy products are expected by 2030, increasing demand for cryogenic and chilled logistics. - Cell and gene therapies are forecast to grow at a 20.5% CAGR through 2035, the fastest rate across product categories. - Individual patient-specific therapy shipments can carry logistics fees above USD 15,000. - Monitoring and data-logging services are advancing at a 13.5% CAGR through 2035. - IoT-enabled temperature monitoring has reduced product loss from temperature excursions by about 18% to 22%. - The report says the installed base of pharmaceutical cold chain sensors exceeded 28 million units in 2024 and could pass 65 million by 2030. - Transportation was the largest service segment in 2024 with a 50.3% share. - Storage held a 33.8% share in 2024. - Vaccines were the largest product segment in 2024 with a 41.0% share. - Biopharmaceuticals accounted for 28.4% of the market in 2024. - Refrigerated shipping at 2-8°C was the largest temperature segment in 2024 with a 45.8% share. - Cryogenic shipping at -80°C and below was the fastest-growing temperature range, at 23.1% CAGR. - Pharmaceutical and biotech manufacturers were the largest end-user segment in 2024 with a 60.2% share. - Contract research organizations were the fastest-growing end-user group, at 12.1% CAGR. - Hospitals and healthcare facilities generated USD 9.8 billion in 2025 revenue. - North America led the market in 2024 with 43.0% of global revenue. - Europe held roughly 26.5% of the global market in 2024. - Asia-Pacific accounted for about 19.5% of global share and is the fastest-growing region, at 10.1% CAGR through 2035. - South America held around 6.2% of global share, and the Middle East and Africa held 4.8%.

Between the lines: - The report shows cold chain logistics is shifting from a back-end shipping function to a technology-heavy compliance system. - Continuous monitoring, validated packaging and digital records are becoming standard requirements, not optional upgrades. - DHL pledged to invest EUR 2 billion by 2030 in cold chain infrastructure and GDP-certified Pharma Hubs. - UPS expanded North American capacity by acquiring Andlauer Healthcare Group for USD 1.6 billion in April 2025. - The U.S. FDA’s DSCSA Phase II serialization requirements took effect in November 2024, adding pressure for digital transaction data exchange. - The report frames emerging markets as a major growth pool, especially where vaccine hub development and cold chain infrastructure are still expanding.

What's next: - The report expects new investment in digital twin tools, predictive analytics and AI-based lane selection. - Sustainable cold chain systems and autonomous last-mile delivery are identified as future growth areas. - Emerging markets are likely to see more regional vaccine hub development and greenfield infrastructure buildout. - The market is projected to keep scaling as biologics adoption and cell therapy commercialization accelerate through 2035.

The bottom line: - Healthcare cold chain logistics is moving into a high-growth decade, with compliance, temperature control and data visibility now central to pharmaceutical distribution.